HighMark Wealth Management’s Mirum Pharmaceuticals MIRM Stock Holding History

HighMark Wealth Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7K	Hold	160	–	–	0.01%	257
2026 Q1	$14.8K	Hold	160	–	–	0.01%	253
2025 Q4	$12.6K	Sell	160 -20	-11%	-$1.44K	0.01%	288
2025 Q3	$13.2K	Hold	180	–	–	0.01%	268
2025 Q2	$9.16K	Hold	180	–	–	﹤0.01%	324
2025 Q1	$8.11K	Hold	180	–	–	﹤0.01%	315
2024 Q4	$7.44K	Hold	180	–	–	﹤0.01%	336
2024 Q3	$7.02K	Sell	180 -85	-32%	-$3.39K	﹤0.01%	355
2024 Q2	$9.06K	Hold	265	–	–	0.01%	294
2024 Q1	$6.66K	Hold	265	–	–	﹤0.01%	343
2023 Q4	$7.82K	Hold	265	–	–	0.01%	301
2023 Q3	$8.37K	Hold	265	–	–	0.01%	280
2023 Q2	$6.86K	Hold	265	–	–	0.01%	313
2023 Q1	$6.37K	Hold	265	–	–	0.01%	359
2022 Q4	$5.17K	Sell	265 -200	-43%	-$3.95K	﹤0.01%	338
2022 Q3	$10K	Hold	465	–	–	0.01%	247
2022 Q2	$9K	Buy	+465	New	+$11K	0.01%	264

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighMark Wealth Management's MIRM Position: Q2 2026 in Review

HighMark Wealth Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 160 shares worth $18.7K. The position accounts for 0.01% of the portfolio, ranked #257.

HighMark Wealth Management first reported a position in MIRM in Q2 2022 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

HighMark Wealth Management held 160 shares of Mirum Pharmaceuticals worth $18.7K as of Q2 2026.
HighMark Wealth Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #257 holding.
HighMark Wealth Management first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.